Yahoo
Tokyo - Delayed Quote JPY

MatsukiyoCocokara & Co. (3088.T)

2,604.00 +79.50 (+3.15%)
At close: October 30 at 3:30:00 PM GMT+9
Chart Range Bar
Loading chart for 3088.T
  • Previous Close 2,524.50
  • Open 2,564.50
  • Bid 2,600.50 x --
  • Ask 2,610.00 x --
  • Day's Range 2,564.00 - 2,615.50
  • 52 Week Range 2,171.50 - 3,026.00
  • Volume 1,599,000
  • Avg. Volume 1,584,318
  • Market Cap (intraday) 1.024T
  • Beta (5Y Monthly) -0.17
  • PE Ratio (TTM) 17.94
  • EPS (TTM) 145.18
  • Earnings Date Nov 13, 2026
  • Forward Dividend & Yield 56.00 (2.15%)
  • Ex-Dividend Date Mar 30, 2027
  • 1y Target Est 3,024.00

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in franchise business development and product supply to franchisees, as well as management support services. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.

www.matsukiyococokara.com

14,293

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

3088.T
1.86%
Nikkei 225 (^N225)
25.73%

1-Year Return

3088.T
4.56%
Nikkei 225 (^N225)
23.31%

3-Year Return

3088.T
7.24%
Nikkei 225 (^N225)
106.18%

5-Year Return

3088.T
68.68%
Nikkei 225 (^N225)
119.05%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 289.35B
Earnings 14.87B
Profit Margin 5.14%

Q2

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
100B
200B
4.8%
5.0%
5.2%
5.4%

Analyst Insights

View More

Analyst Price Targets

2,420.00
3,024.00 Average
2,604.00 Current
3,750.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.09%

  • Return on Assets (ttm)

    7.57%

  • Return on Equity (ttm)

    11.10%

  • Revenue (ttm)

    1.13T

  • Net Income Avi to Common (ttm)

    57.7B

  • Diluted EPS (ttm)

    145.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    101.47B

  • Total Debt/Equity (mrq)

    0.28%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: